Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stolley

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
JAMA|July 6, 1984
Noncontraceptive estrogen use and the risk of breast cancerD W Kaufman, D R Miller, L Rosenberg, et al.
American Journal of Epidemiology|March 15, 1991
Endometrial cancer and age at last delivery: evidence for an associationS M Lesko, L Rosenberg, D W Kaufman, et al.
Neoplasma|January 1, 1983
T-cell hybrids. IV. One of parental cell lines is dominant in determining membrane characteristics of hybrid cellsJ Bubeník, G Dreyer, C Junge, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-upD S Metzger, G E Woody, A T McLellan, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
JAMA|July 6, 1984
Noncontraceptive estrogen use and the risk of breast cancerD W Kaufman, D R Miller, L Rosenberg, et al.
American Journal of Epidemiology|March 15, 1991
Endometrial cancer and age at last delivery: evidence for an associationS M Lesko, L Rosenberg, D W Kaufman, et al.
Neoplasma|January 1, 1983
T-cell hybrids. IV. One of parental cell lines is dominant in determining membrane characteristics of hybrid cellsJ Bubeník, G Dreyer, C Junge, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-upD S Metzger, G E Woody, A T McLellan, et al.
Pageof 3